Sign in →

Page 1423 of 2004 Tests Beginning with H 50099 entries

HIVP  HIV-1 DNA and RNA Qualitative Detection by PCR, Plasma Mayo Clinic Laboratories in Rochester
HIVP  HIV-1 DNA and RNA Qualitative Detection by PCR, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester
HIVDR  HIV-1 Genotypic Drug Resistance to Reverse Transcriptase, Protease, and Integrase Inhibitors, Plasma Mayo Clinic Laboratories in Rochester